Perianal fistulas in Crohn's disease (review)
https://doi.org/10.33878/2073-7556-2023-22-1-128-137
Abstract
Treatment of аnal fistulas as perianal manifestations of Crohn’s disease is an important task, the solution of which has not yet been found. First of all, this is due to debilitating symptoms that reduce the quality of life. Incorrect tactics in the treatment of this disease can lead to the development of anal incontinence, and in some cases to the removal of the rectum. The purpose of this review was to study the effectiveness of various surgical methods for the treatment of perianal fistulas, the features of their use in various types of fistulas, as well as to assess the impact of surgical treatment on the function of the anal sphincter. It was found that most of the described methods were used in a strictly selected limited group of patients and allowed only temporary elimination of the clinical manifestations of Crohn’s disease. Unsatisfactory results of treatment, especially in the late postoperative period, a small number of clinical observations in published scientific papers on the treatment of perianal manifestations of Crohn’s disease, as well as low reliability of the results, dictate the need for further studies involving more patients.
About the Authors
I. S. Anosov
Ryzhih National Medical Research Centreof Coloproctology
Russian Federation
Russian Federation
Ivan S. Anosov
Salyama Adilya st., 2, Moscow, 123423
B. A. Nanaeva
Ryzhih National Medical Research Centreof Coloproctology
Bella A. Nanaeva
Salyama Adilya st., 2, Moscow, 123423
A. V. Vardanyan
Ryzhih National Medical Research Centreof Coloproctology
Armen V. Vardanyan
Salyama Adilya st., 2, Moscow, 123423
M. A. Zakharov
Ryzhih National Medical Research Centreof Coloproctology
Mark A. Zakharov
Salyama Adilya st., 2, Moscow, 123423
References
1. Loffler T, Welsch T, Muhl S, et al. Long-term success rate after surgical treatment of anorectal and rectovaginal fistulas in Crohn’s disease. Int J Colorectal Dis. 2009;24(5):521–526. doi: 10.1007/s00384-009-0638-x
2. Bolshinsky V, Church J. Management of Complex Anorectal and Perianal Crohn’s Disease. Clin Colon Rectal Surg. 2019;32:255–260. doi: 10.1055/s-0039-1683907
3. Feuerstein JD, Cheifetz AS. Crohn disease: Epidemiology, diagnosis, and management. Mayo Clin Proc. 2017;92:1088–1103. doi: 10.1016/j.mayocp.2017.04.010
4. Panés J, Rimola J. Perianal fistulizing Crohn’s disease: pathogenesis, diagnosis and therapy. Nat Rev Gastroenterol Hepatol. 2017;14:652–64. doi: 10.1038/nrgastro.2017.104
5. Park SH, Aniwan S, Scott Harmsen W, Tremaine WJ, et al. Update on the natural course of fistulizing perianal Crohn’s disease in a population-based cohort. Inflamm Bowel Dis. 2019;25:1054–60. doi: 10.1093/ibd/izy329
6. Schwartz DA, Loftus EV, Jr., Tremaine WJ, et al. The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology. 2002;122(4):875–80. doi: 10.1053/gast.2002.32362
7. Molendijk I, Nuij VJ, van der Meulen-de Jong AE, et al. Disappointing durable remission rates in complex Crohn’s disease fistula. Inflamm Bowel Dis. 2014;20(11):2022–2028. doi: 10.1097/MIB.0000000000000148
8. Ivashkin V.T., Sheligin Yu.A., Abdulganieva D.I. Clinical guidelines for the diagnosis and treatment of Crohn’s disease in adults (project). Koloproktologia. 2020;19(2):8–32. (in Russ.). doi: 10.33878/2073-7556-2020-19-2-8-38
9. Sandborn WJ, Fazio VW, Feagan BG, et al. American Gastroenterological Association Clinical Practice Committee. AGA technical review on perianal Crohn’s disease. Gastroenterology. 2003;125:1508–30. doi: 10.1016/j.gastro.2003.08.025
10. Santillan CS, Huang C, Eisenstein S, et al. MRI of Perianal Crohn Disease: Technique and Interpretation. Top Magn Reson Imaging. 2021;1;30(1):63–76. doi: 10.1097/RMR.0000000000000268
11. van Rijn KL, Meima-van Praag EM, Bossuyt PM, et al. Fibrosis and MAGNIFI-CD Activity Index at Magnetic Resonance Imaging to Predict Treatment Outcome in Perianal Fistulizing Crohn’s Disease Patients. J Crohns Colitis. 2022;16(5):708–716. doi: 10.1093/eccojcc/jjab168
12. Gallego JC, Echarri A. Role of magnetic resonance imaging in the management of perianal Crohn’s disease. Insights Imaging. 2018;9(1):47–58. doi: 10.1007/s13244-017-0579-9
13. Halligan S, Stoker J. Imaging of fistula in ano. Radiology. 2006;239:18–33.
14. Bell SJ, Halligan S, Windsor AC, et al. Response of fistulating Crohn’s disease to infliximab treatment assessed by magnetic resonance imaging. Aliment Pharmacol Ther. 2003;17:387–93.
15. Zawadzki A, Starck M, Bohe M, Thorlacius H. A unique 3D endoanal ultrasound feature of perianal Crohn’s fistula: the ‘Crohn ultrasound fistula sign’. Colorectal Dis. 2012;14(9):e608-11. doi: 10.1111/j.1463-1318.2012.03047.x
16. Gecse KB, Bemelman W, Kamm MA, et al. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease. Gut. 2014;63:1381–1392. doi: 10.1136/gutjnl-2013-306709
17. Lopez N., Ramamoorthy S., Sandborn W.J. Recent advances in the management of perianal fistulizing Crohn’s disease: lessons for the clinic. Expert Rev Gastroenterol Hepatol. 2019;13(6):563–577. doi: 10.1080/17474124.2019.1608818
18. Alabiso ME, Iasiello F, Pellino G, et al. 3D-EAUS and MRI in the Activity of Anal Fistulas in Crohn’s Disease. Gastroenterol Res Pract. 2016;2016:1895694. doi: 10.1155/2016/1895694
19. Schwartz DA, Wiersema MJ, Dudiak KM, et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn’s perianal fistulas. Gastroenterology. 2001;121:1064–72. doi: 10.1053/gast.2001.28676
20. Kotze PG, Spinelli A, Lightner AL. Cell-based Therapy for Perianal Fistulising Crohn’s Disease. Curr Pharm Des. 2019;25:41–46. doi: 10.2174/1381612825666190308095651
21. Panés J, García-Olmo D, Van Assche G, et al. ADMIRE CD Study Group Collaborators. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a phase 3 randomised, double-blind controlled trial. Lancet. 2016;388:1281–1290. doi: 10.1016/S0140-6736(16)31203-X
22. Lightner AL, Wang Z, Zubair AC, et al. A Systematic Review and Meta-analysis of Mesenchymal Stem Cell Injections for the Treatment of Perianal Crohn’s Disease: Progress Made and Future Directions. Dis Colon Rectum. 2018;61:629–640. doi: 10.1097/DCR.0000000000001093
23. Adegbola SO, Sahnan K, Tozer PJ, et al. Review of local injection of anti-TNF for perianal fistulising Crohn’s disease. Int J Colorectal Dis. 2017;32:1539–1544. doi: 10.1007/s00384-017-2899-0
24. Dulai PS, Buckey JC Jr, Raffals LE, et al. Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial. Am J Gastroenterol. 2018;113:1516–1523. doi: 10.1038/s41395-018-0005-z
25. Gecse KB, Bemelman W, Kamm MA, et al. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease. Gut. 2014;63(9):1381–92. doi: 10.1136/gutjnl-2013-306709
26. El-Gazzaz G, Hull T, Church JM. Biological immunomodulators improve the healing rate in surgically treated perianal Crohn’s fistulas. Colorectal Dis. 2012;14(10):1217–23. doi: 10.1111/j.1463-1318.2012.02944.x
27. Lozynskyy YS. Treatment algorithms in the case of perianal complications of Crohn’s disease. Dig Dis. 2009;27(4):565–70. doi: 10.1159/000233299
28. Lichtenstein GR, Loftus EV, Isaacs KL, et al. ACG Clinical Guideline: Management of Crohn’s Disease in Adults. Am J Gastroenterol. 2018;113(4):481–517. doi: 10.1038/ajg.2018.27
29. Bemelman WA, Warusavitarne J, Sampietro GM, et al. ECCOESCP Consensus on Surgery for Crohn’s Disease. J Crohns Colitis. 2018;12(1):1–16. doi: 10.1093/ecco-jcc/jjx061
30. Lee MJ, Heywood N, Adegbola S, et al. Systematic review of surgical interventions for Crohn’s anal fistula. BJS Open. 2017;1(3):55– 66. doi: 10.1002/bjs5.13
31. Graf W, Andersson M, Åkerlund JE, et al. Long-term outcome after surgery for Crohn’s anal fistula. Colorectal Dis. 2016;18:80–85. doi: 10.1111/codi.13106
32. Dursun A, Hodin R, Bordeianou L. Impact of perineal Crohn’s disease on utilization of care in the absence of modifiable predictors of treatment failure. Int J Colorectal Dis. 2014;29:1535–1539. doi: 10.1007/s00384-014-2013-9
33. van Koperen PJ, Safiruddin F, Bemelman WA, et al. Outcome of surgical treatment for fistula in ano in Crohn’s disease. Br J Surg. 2009;96(6):675–9. doi: 10.1002/bjs.6608
34. Antakia R, Shorthouse AJ, Robinson K, et al. Combined modality treatment for complex fistulating perianal Crohn’s disease. Colorectal Dis. 2013;15(2):210–6. doi: 10.1111/j.1463-1318.2012.03124.x
35. Seyfried S, Herold A. Management of Perianal Fistulas in Crohn’s Disease. Visc Med. 2019;35:338–343. doi: 10.1159/000504103
36. Boscá MM, Alós R, Maroto N, et al. Recommendations of the Crohn’s Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn’s disease. Gastroenterol Hepatol. 2020;43:155–168. doi: 10.1016/j.gastrohep.2019.09.012
37. Buchanan GN, Owen HA, Torkington J, et al. Long-term outcome following loose-seton technique for external sphincter preservation in complex anal fistula. Br J Surg. 2004;91:476–480. doi: 10.1002/bjs.4466
38. Chung W, Ko D, Sun C, et al. Outcomes of anal fistula surgery in patients with inflammatory bowel disease. Am J Surg. 2010;199:609– 613. doi: 10.1016/j.amjsurg.2010.01.007
39. Sciaudone G, Di Stazio C, Limongelli P, et al. Treatment of complex perianal fistulas in Crohn disease: infliximab, surgery or combined approach. Can J Surg. 2010;53:299–304
40. Sugita A, Koganei K, Harada H, et al. Surgery for Crohn’s anal fistulas. J Gastroenterol. 1995;30(8):143–146
41. Uchino M, Ikeuchi H, Bando T, et al. Long-term efficacy of infliximab maintenance therapy for perianal Crohn’s disease. World J Gastroenterol. 2011;17:1174–1179. doi: 10.3748/wjg.v17.i9.1174
42. Poritz LS, Rowe WA, Koltun WA. Remicade does not abolish the need for surgery in fistulizing Crohn’s disease. Dis Colon Rectum. 2002;45(6):771–5. doi: 10.1007/s10350-004-6296-8
43. Hukkinen M, Pakarinen MP, Piekkala M, et al. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn’s disease. J Crohns Colitis. 2014;8(8):756–62. doi: 10.1016/j.crohns.2014.01.001
44. Bouguen G, Siproudhis L, Gizard E, et al. Long-term outcome of perianal fistulizing Crohn’s disease treated with infliximab. Clin Gastroenterol Hepatol. 2013;11(8):975–81 e1-4. doi: 10.1016/j.cgh.2012.12.042
45. Tanaka S, Matsuo K, Sasaki T, et al. Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn’s disease: when and how were the seton drains removed? Hepatogastroenterology. 2010;57(97):3–7.
46. Kotze PG, Albuquerque IC, da Luz Moreira A, et al. Perianal complete remission with combined therapy (seton placement and anti-TNF agents) in Crohn’s disease: a Brazilian multicenter observational study. Arq Gastroenterol. 2014;51:284–289. doi: 10.1590/S0004-28032014000400004
47. Ritchie RD, Sackier JM, Hodde JP. Incontinence rates after cutting seton treatment for anal fistula. Colorectal Dis. 2009;11(6):564– 571. doi: 10.1111/j.1463-1318.2008.01713.x
48. Williams JG, MacLeod CA, Rothenberger DA et al. Seton treatment of high anal fistulae. Br J Surg. 1991;78:1159–61. doi: 10.1002/bjs.1800781004
49. Wasmann KA, de Groof EJ, Stellingwerf ME, et al. Treatment of Perianal Fistulas in Crohn’s Disease, Seton Versus Anti-TNF Versus Surgical Closure Following Anti-TNF [PISA]: A Randomised Controlled Trial. J Crohns Colitis. 2020;14:1049–1056. doi: 10.1093/ecco-jcc/jjaa004
50. de Groof EJ, Sahami S, Lucas C, et al. Treatment of perianal fistula in Crohn’s disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment. Colorectal Dis. 2016;18(7):667–675. doi: 10.1111/codi.13311
51. El-Gazzaz G, Hull T, Mignanelli E, et al. Analysis of function and predictors of failure in women undergoing repair of Crohn’s related rectovaginal fistula. J Gastrointest Surg. 2010;14(5):824–9. doi: 10.1007/s11605-010-1167-1
52. Andreani SM, Dang HH, Grondona P, et al. Rectovaginal fistula in Crohn’s disease. Dis Colon Rectum. 2007;50(12):2215–22. doi: 10.1007/s10350-007-9057-7
53. Jarrar A, Church J. Advancement flap repair: a good option for complex anorectal fistulas. Dis Colon Rectum. 2011;54(12):1537–41. doi: 10.1097/DCR.0b013e31822d7ddd
54. Soltani A, Kaiser AM. Endorectal advancement flap for cryptoglandular or Crohn’s fistula-in-ano. Dis Colon Rectum. 2010;53(4):486– 95. doi: 10.1007/DCR.0b013e3181ce8b01
55. Roper MT, Trinidad SM, Ramamoorthy SL, et al. Endorectal Advancement Flaps for Perianal Fistulae in Crohn’s Disease: Careful Patient Selection Leads to Optimal Outcomes. J Gastrointest Surg. 2019;23:2277–2284. doi: 10.1007/s11605-019-04205-0
56. Stellingwerf ME, van Praag EM, Tozer PJ, et al. Systematic review and meta-analysis of endorectal advancement flap and ligation of the intersphincteric fistula tract for cryptoglandular and Crohn’s high perianal fistulas. BJS Open. 2019;3:231–241. doi: 10.1002/bjs5.50129
57. van Praag EM, Stellingwerf ME, van der Bilt JDW, et al. Ligation of the Intersphincteric Fistula Tract and Endorectal Advancement Flap for High Perianal Fistulas in Crohn’s Disease: A Retrospective Cohort Study. J Crohns Colitis. 2020;14:757–763. doi: 10.1093/ecco-jcc/jjz181
58. Makowiec F, Jehle EC, Becker HD, et al. Clinical course after transanal advancement flap repair of perianal fistula in patients with Crohn’s disease. Br J Surg. 1995;82(5):603–6. doi: 10.1002/bjs.1800820509
59. Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn’s disease. N Engl J Med. 2010;362:1383–1395. doi: 10.1056/NEJMoa0904492
60. DIAMOND study group. Clinical and Pharmacokinetic Factors Associated with Adalimumab-Induced Mucosal Healing in Patients with Crohn’s Disease. Clin Gastroenterol Hepatol. 2018;16:542–549. doi: 10.1016/j.cgh.2017.10.036
61. Lichtenstein G, Yan S, Bala M, et al. Infliximab Maintenance Treatment Reduces Hospitalizations, Surgeries, and Procedures in Fistulizing Crohn’s Disease. Gastro. 2005;128:862–869. doi: 10.1053/j.gastro.2005.01.048
62. Ji CC, Takano S. Clinical Efficacy of Adalimumab versus Infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn’s disease. Intest Res. 2017;15(2):182–186. doi: 10.5217/ir.2017.15.2.182
63. Regh KL, Sanchez JE, Krieger BR, et al. Fecal diversion in perirectal fistulizing Crohn’s disease is an underutilized and potentially temporary means of successful treatment. Am Surg. 2009;75(8):715–8.
64. Kotze PG, Shen B, Lightner A, et al. Modern management of perianal fistulas in Crohn’s disease: future directions. Gut. 2018;67:1181–1194. doi: 10.1136/gutjnl-2017-314918
65. Wood T, Truong A, Mujukian A, et al. Increasing experience with the LIFT procedure in Crohn’s disease patients with complex anal fistula. Tech Coloproctol. 2022;26(3):205–212. doi: 10.1007/s10151-022-02582-4
66. Gingold DS, Murrell ZA, Fleshner PR. A prospective evaluation of the ligation of the intersphincteric tract procedure for complex anal fistula in patients with Crohn’s disease. Ann Surg. 2014;260(6):1057–61. doi: 10.1097/SLA.0000000000000479
67. Kaminski JP, Zaghiyan K, Fleshner P. Increasing experience of ligation of the intersphincteric fistula tract for patients with Crohn’s disease: what have we learned? Colorectal Dis. 2017;19(8):750–755. doi: 10.1111/codi.13668
68. Grolich T, Skricka T, Robek O, et al. Role of video assisted anal fistula treatment in our management of fistula-in-ano. Acta Chir Iugosl. 2014;61(2):83–5. doi: 10.2298/ACI1402083G
69. Emile SH, Elfeki H, Shalaby M, et al. A Systematic review and meta-analysis of the efficacy and safety of video-assisted anal fistula treatment (VAAFT). Surg Endosc. 2018;32(4):2084–2093. doi: 10.1007/s00464-017-5905-2
70. Schwandner O. Video-assisted anal fistula treatment (VAAFT) combined with advancement flap repair in Crohn’s disease. Tech Coloproctol. 2013;17(2):221–225. doi: 10.1007/s10151-012-0921-7
71. Adegbola SO, Sahnan K, Tozer PJ, et al. Symptom Amelioration in Crohn’s Perianal Fistulas Using Video-Assisted Anal Fistula Treatment (VAAFT). J Crohns Colitis. 2018;12:1067–1072. doi: 10.1093/eccojcc/jjy071
72. Wilhelm A., Fiebig A., Krawezak M. Five years of experience with the FiLaC laser for fistula-in-ano management long-term follow up from a single institution. Tech Coloproctol. 2017;21:269–276. doi: 10.1007/s10151-017-1599-7
73. Matinyan A.V., Kostarev I.V., Blagodarny L.A., et al. Fistula laser ablation for of anal fistulas (systematic review). Koloproctologia. 2019;18(3):7–19. (in Russ.). doi: 10.33878/2073-7556-2019-18-3-7-19
74. Mustafa CT, Cihan A, et al. Closing Perianal Fistulas Using a Laser: Long-Term Results in 103 Patients. Dis Colon Rectum. 2018;61:5:00– 00. doi: 10.1097/DCR.0000000000001038
75. Elfeki H, Shalaby M, Emile SH, et al. A systematic review and meta-analysis of the safety and efficacy of fistula laser closure. Tech Coloproctol. 2020;24(4):265–274. doi: 10.1007/s10151-020-02165-1
76. Moy J, Bodzin J. Carbon dioxide laser ablation of perianal fistulas in patients with Crohn’s disease: experience with 27 patients. Am J Surg. 2006;191:424–427. doi: 10.1016/j.amjsurg.2005.10.050
77. Stijns J, van Loon YT, Clermonts SHEM, et al. Implementation of laser ablation of fistula tract (LAFT) for perianal fistulas: do the results warrant continued application of this technique? Tech Coloproctol. 2019;23:1127–1132. doi: 10.1007/s10151-019-02112-9
78. Alam A, Lin F, Fathallah N, et al. FiLaC® and Crohn’s disease perianal fistulas: a pilot study of 20 consecutive patients. Tech Coloproctol. 2020;24:75–78. doi: 10.1007/s10151-019-02134-3
79. Cao D, Li W, Ji Y, et al. Efficacy and safety of FiLaC™ for perianal fistulizing Crohn’s disease: a systematic review and meta-analysis. Tech Coloproctol. 2022;26(10):775–781. doi: 10.1007/s10151-022-02682-1
80. O’Riordan JM, Datta I, Johnston C, et al. A systematic review of the anal fistula plug for patients with Crohn’s and non-Crohn’s related fistula-in-ano. Dis Colon Rectum. 2012;55(3):351–358. doi: 10.1097/DCR.0b013e318239d1e4
81. Nasseri Y, Cassella L, Berns M, et al. The anal fistula plug in Crohn’s disease patients with fistula-in-ano: a systematic review. Colorectal Dis. 2016;18(4):351–356. doi: 10.1111/codi.13268
82. Senéjoux A, Siproudhis L, Abramowitz L, et al. Thérapeutique des Affections Inflammatoires du tube Digestif [GETAID] Fistula Plug in Fistulising Ano-Perineal Crohn’s Disease: a Randomised Controlled Trial. J Crohns Colitis. 2016;10:141–148. doi: 10.1093/ecco-jcc/jjv162
83. Grimaud JC, Munoz-Bongrand N, Siproudhis L, et al. Fibrin glue is effective healing perianal fistulas in patients with Crohn’s disease. Gastroenterology. 2010;138(7):2275–2281,2281 e2271. doi: 10.1053/j.gastro.2010.02.013
84. Truong A, Zaghiyan K, Fleshner P. Anorectal Crohn’s Disease. Surg Clin North Am. 2019;99:1151–1162. doi: 10.1016/j.suc.2019.08.012
85. Yamamoto T, Bain IM, Allan RN, et al. Persistent perineal sinus after proctocolectomy for Crohn’s disease. Dis Colon Rectum. 1999;42:96–101. doi: 10.1007/BF02235190
86. Singh S, Ding NS, Mathis KL, et al. Systematic review with metaanalysis: faecal diversion for management of perianal Crohn’s disease. Aliment Pharmacol Ther. 2015;42(7):783–792. doi: 10.1111/apt.13356
87. Coscia M, Gentilini L, Laureti S, et al. Risk of permanent stoma in extensive Crohn’s colitis: the impact of biological drugs. Colorectal Dis. 2013;15(9):1115–22. doi: 10.1111/codi.12249
88. Mueller MH, Geis M, Glatzle J, Kasparek M, et al. Risk of fecal diversion in complicated perianal Crohn’s disease. J Gastrointest Surg. 2007;11(4):529–37. doi: 10.1007/s11605-006-0029-3
89. de Groof EJ, van der Meer JHM, Tanis PJ, et al. Persistent Mesorectal Inflammatory Activity is Associated With Complications After Proctectomy in Crohn’s Disease. J Crohns Colitis. 2019;13:285– 293. doi: 10.1093/ecco-jcc/jjy131
90. Zabot GP, Cassol O, Saad-Hossne R, et al. Modern surgical strategies for perianal Crohn’s disease. World J Gastroenterol. 2020;26(42):6572–6581. doi: 10.3748/wjg.v26.i42.6572
91. Shelygin Yu.A., Kashnikov V.N., Bolikhov K.V., et al. Predictors of efficacy for ileostomy in complicated forms of Crohn’s disease involving large intestine. Annaly khirurgii. 2012;3:37–42. (in Russ.).
Review
For citations:
Anosov I.S., Nanaeva B.A., Vardanyan A.V., Zakharov M.A. Perianal fistulas in Crohn's disease (review). Koloproktologia. 2023;22(1):128-137. https://doi.org/10.33878/2073-7556-2023-22-1-128-137
Views:
1632
Email this article 
